Trials / Not Yet Recruiting
Not Yet RecruitingNCT06491199
Home Assessment of Blood Pressure in PregnancY
HABPY: Home Assessment of Blood Pressure in PregnancY
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- Female
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to evaluate the feasibility and safety of a comprehensive home blood pressure telemonitoring (HBPT) program for pregnant people with hypertensive disorders of pregnancy (HDP). Participants will receive training on the use of a home BP telemonitor with tele-transmission function for the remainder of their pregnancy and 6 weeks postpartum. Participating obstetric internal medicine (OBIM) clinicians will monitor the transmitted values and adjust anti-hypertensive medications based on the home BP readings. Our primary goal is to describe the feasibility and safety of a comprehensive HBPT pilot program in British Columbia, Canada (BC). Secondary research questions will address: 1. What is the end-user acceptability of a comprehensive HBPT pilot program in BC? 2. What are the effects of a comprehensive HBPT pilot program on factors such as: 1\. Maternal and neonatal outcomes 2. Home blood pressure (BP) metrics 3. Process measures 4. Anti-hypertensive medications 5. Fidelity to interventions 6. Health Care utilization
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Home blood pressure telemonitoring program and clinician monitoring | Home Blood Pressure Telemonitoring (HBPT) includes used of an app to collect and transmit blood pressure readings. Clinician monitoring includes OBIM physicians reviewing transmitted BP data and contacting patients to adjust antihypertensive medication regimens. |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2026-01-01
- Completion
- 2026-01-01
- First posted
- 2024-07-09
- Last updated
- 2024-07-09
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06491199. Inclusion in this directory is not an endorsement.